In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these meetings, they intend to reaffirm the company’s shareholders’ earnings guidance for FY25 to be $30.40-$31.10 per diluted share, including approximately $3.75 per diluted share of net unfavorable items. Excluding these items, the company continues to expect adjusted shareholders’ earnings to be $34.15-$34.85 per diluted share. Consensus is $34.49. In addition, the company continues to expect 2025 year-end total medical enrollment to be consistent with the guidance provided in its Q4 earnings release, dated January 23, including expectations for Medicare Advantage membership of 2.2M-2.25M members.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Cooperman’s Omega Advisors buys KBR, cuts Fiserv in Q4
- Trump Trade: President advocates to close carried interest tax loophole
- Elevance Health to buy insurance business from Alphabet’s Verily, Insider says
- White House readying order to fire thousands of federal health workers, WSJ says
- DOGE team searching CMS payment system for fraud, WSJ reports
Questions or Comments about the article? Write to editor@tipranks.com